The global perfusion imaging market is slated to create a revenue of almost US$ 2,421.4 million in 2024 owing to its rising importance in healthcare facilities. As per FMI, the perfusion imaging market is set to surge at a CAGR of 3.4% from 2024 to 2034. The net worth of the perfusion imaging industry is estimated at almost US$ 3,382.8 million by 2034 following this fair growth rate.
Rising prevalence of myocardial infarction and ischemic heart disease has increased the need for perfusion imaging equipment in the medical field. Along with that, a growing inclination toward non-invasive diagnostic methods has boosted its adoption in modern healthcare facilities as well as clinics.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-9650
Key Takeaways from the Perfusion Imaging Market Study Report:
- The United States is witnessing a comparatively slow growth rate of 1.9% due to market saturation that is estimated to continue till 2034.
- Germany holds a significant share of the European diagnostic imaging market and is penned in to advance at 2.5% CAGR between 2024 and 2034.
- In Asia, India is currently creating a noticeable demand for perfusion scanners resulting in an estimated CAGR of 5.0% for the projected years.
- Thailand is another steadily growing market with an estimated CAGR of 3.5% from 2024 to 2034.
Competitive Landscape for the Perfusion Imaging Market Players:
The overall market is diversifying slowly with government support in emerging economies to their regional players. Better image resolution, speed, and accuracy of perfusion imaging solutions from leading market players are becoming more useful for diagnosing and tracking a wide range of medical disorders. Meanwhile, emerging market players are resorting to collaborations and mergers with big players to gain technical advantage in their respective regions.
“Prevalence of neurological and cardiovascular illnesses, particularly in the United States and Europe, has resulted in a highly developed healthcare system for adoption of perfusion scanning equipment and technologies. However, swift developing economies such as India, China, and South Korea are strengthening their healthcare infrastructure favoring the regional diagnostic imaging market in Asia,” – says a lead analyst at FMI.
Recent Developments by the Perfusion Imaging Industry Participants:
- In November 2023, Brainomix, based in the United States, announced the release of its entire suite of FDA-cleared components in its Brainomix 360 platform which is an integrated stroke imaging solution. The firm had previously announced an FDA-cleared e-ASPECTS component which presents a platform designed to help doctors make imaging-based treatment decisions at all stages of the stroke pathway. The Brainomix 360 e-ASPECTS smartphone app is also an FDA-cleared decision support tool for evaluating stroke symptoms on plain CT brain imaging.
- In March 2024, Lantheus Holdings Incorporated, based in the United States, announced that the Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere). It can be used as an ultrasound-enhancing agent for use in pediatric patients with suboptimal echocardiograms. This clearance marks a significant advancement in pediatric medicine and DEFINITY boasts of being the most widely used, well-researched, and reliable diagnostic ultrasound-enhancing agent in the country.
Key Players Profiled in the Perfusion Imaging Market Report:
- GE Healthcare
- Toshiba Medical System.
- Positron
- Aetna Inc.
- NeuSoft
- Bracco
- Cigna
- Kmhlabs
- Perimed AB.
- Siemens Health
- Philips Healthcare
- Lantheus Medical Cardiac Imaging Solutions Inc.
Key Segments Covered by Perfusion Imaging Industry Survey Report:
By Modality Type:
- Single Photon Emission Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
- Magnetic Resonance Imaging (MRI)
- Computed tomography (CT)
- Doppler echocardiography
By Application:
- Coronary artery disease (CAD)
- Myocardial infarction (MI)
- Cardiomyopathy
- Epilepsy
- Dementia
- Transplant evaluation
- Brain Trauma
- Pulmonary embolism (PE)
- Osteonecrosis
- Other Applications
By End User Verticals:
- Hospitals
- Ambulatory Surgery Center
- Diagnostic Imaging Centers
- Other End Users
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
The Wall